Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × binimetinib × Dermatologic × Clear all

Phase

Status

Completed 11 Terminated 8 Recruiting 7 Active not recruiting 7 Unknown 4 Withdrawn 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Nivolumab 3 relatlimab 2 pembrolizumab 2 Standard of Care 2 Photochemotherapy 2 Melphalan 2 Ipilimumab 2 Interleukin-2 2 Fluorouracil 2 Dermoscopy 2 Cryotherapy 2 trametinib 1 toripalimab 1 tirbanibulin 1 sulforaphane 1 secukinumab 1 encorafenib 1 decitabine and cedazuridine drug combination 1 daromun 1 cemiplimab 1 calcipotriene 1 binimetinib 1 anlotinib 1 Watchful Waiting 1 Vitamin D 1 Toll-Like Receptor 1 1 Therapeutics 1 Surveys and Questionnaires 1 Sunscreening Agents 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092410 2025-07-29

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡